PHASE-II STUDY OF CHLOROZOTOCIN IN LEUKEMIA AND OTHER HEMATOLOGIC MALIGNANCIES

被引：0
|
作者：
PAVLOVSKY, S
WOOLLEY, PV
GARAY, G
SCAGLIONE, C
HOTH, D
SCHEIN, PS
机构：
[1] GEORGETOWN UNIV, MED CTR, DEPT MED, WASHINGTON, DC 20007 USA
[2] GEORGETOWN UNIV, MED CTR, DIV MED ONCOL, WASHINGTON, DC 20007 USA
[3] GEORGETOWN UNIV, MED CTR, VINCENT T LOMBARDI CANC RES CTR, WASHINGTON, DC 20007 USA
[4] ACAD NACL MED, INST INVEST HEMATOL, BUENOS AIRES, ARGENTINA
来源：
CANCER TREATMENT REPORTS | 1981年 / 65卷 / 11-1期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Chlorozotocin is a glucose-containing chloroethylnitrosourea that is relatively nonmyelosuppressive at doses that produce significant antileukemic activity in L1210 murine leukemia. The present phase II trial tested chlorozotocin using the nonmyelosuppressive 120-mg/m2 dose in leukemia and lymphoma patients. This dose was given weekly or daily for 3 days to the leukemia patients and every 6 wk to the lymphoma patients. Chlorozotocin was not effective in heavily pretreated leukemia and lymphoma patients but gave evidence of activity, particularly in Hodgkin''s disease, that might be exploited in a less heavily treated population.
引用
收藏
页码：1109 / 1111
页数：3
相关论文
共 50 条
  • [1] VINDESINE IN THE TREATMENT OF REFRACTORY HEMATOLOGIC MALIGNANCIES - A PHASE-II STUDY
    MANDELLI, F
    AMADORI, S
    GIONA, F
    ANTONIETTA, M
    SPIRITI, A
    PASTORE, S
    MELONI, G
    PAOLUCCI, G
    LEUKEMIA RESEARCH, 1982, 6 (05) : 649 - 652
  • [2] PHASE-II EVALUATION OF VINDESINE IN MYCOSIS-FUNGOIDES, EXTRAOSSEOUS PLASMACYTOMA AND OTHER HEMATOLOGIC MALIGNANCIES
    FERRAZZI, E
    PAPPAGALLO, GL
    SEGATI, R
    VINANTE, O
    GALLIGIONI, E
    ZAGONEL, V
    SALVAGNO, L
    FIORENTINO, MV
    TUMORI, 1982, 68 (04) : 321 - 324
  • [3] A CLINICAL-TRIAL OF CHLOROZOTOCIN IN LYMPHOMAS, LEUKEMIAS AND OTHER HEMATOLOGIC MALIGNANCIES
    WOOLLEY, PV
    PAVLOVSKY, S
    SCHEIN, P
    ROSENOFF, S
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1980, 21 (MAR): : 156 - 156
  • [4] PHASE-II EVALUATION OF CHLOROZOTOCIN IN METASTATIC SARCOMAS
    PRESANT, CA
    BARTOLUCCI, AA
    MEDICAL AND PEDIATRIC ONCOLOGY, 1984, 12 (01): : 25 - 27
  • [5] CHLOROZOTOCIN - PHASE-II EVALUATION IN PATIENTS WITH MYELOMA
    CORNELL, CJ
    PAJAK, TF
    MCINTYRE, OR
    CANCER TREATMENT REPORTS, 1984, 68 (04): : 685 - 686
  • [6] PHASE-II STUDY OF CHLOROZOTOCIN IN THE TREATMENT OF ADVANCED COLORECTAL-CANCER
    LAWTON, JO
    GILES, GR
    HALL, J
    MACADAM, A
    HALL, R
    MATHESON, T
    BIRD, G
    CANCER TREATMENT REPORTS, 1981, 65 (1-2): : 13 - 15
  • [7] PHASE-II CLINICAL-TRIALS WITH VINDESINE IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES
    MATHE, G
    HULHOVEN, R
    SOKAL, G
    BAYSSAS, M
    BELPOMME, D
    BOSLY, A
    CORNU, G
    DELANNOY, A
    DELUCA, L
    DEVASSAL, F
    FERRANT, A
    GOUVEIA, J
    HAYAT, M
    JASMIN, C
    MACHOVER, D
    MICHAUX, JL
    MISSET, JL
    MUSSET, M
    PICO, JL
    RIBAUD, P
    SCHWARTZENBERG, L
    ANTICANCER RESEARCH, 1981, 1 (01) : 1 - 9
  • [8] CHLOROZOTOCIN - PHASE-II EVALUATION IN PATIENTS WITH ADVANCED SARCOMAS
    SORDILLO, PP
    MAGILL, GB
    GRALLA, RJ
    CANCER TREATMENT REPORTS, 1981, 65 (5-6): : 513 - 514
  • [9] PHASE-II STUDY OF MAYTANSINE AND CHLOROZOTOCIN IN PATIENTS WITH DISSEMINATED MALIGNANT-MELANOMA
    AHMANN, DL
    FRYTAK, S
    KVOLS, LK
    HAHN, RG
    EDMONSON, JH
    BISEL, HF
    CREAGAN, ET
    CANCER TREATMENT REPORTS, 1980, 64 (4-5): : 721 - 723
  • [10] PHASE-II EVALUATION OF CHLOROZOTOCIN IN PATIENTS WITH MALIGNANT-MELANOMA
    HOUGHTON, AN
    CAMACHO, FJ
    GRALLA, RJ
    WITTES, R
    CANCER TREATMENT REPORTS, 1981, 65 (7-8): : 705 - 706
12345